Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stem cell transplantation in systemic lupus erythematous, a mesenchymal stem cell disorder
Anwar Fathollahi, N B Gabalou, Saeed Aslani
Lupus (2018) Vol. 27, Iss. 7, pp. 1053-1064
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Mesenchymal Stem Cell-Derived Secretome: A Potential Therapeutic Option for Autoimmune and Immune-Mediated Inflammatory Diseases
Györgyi Műzes, Ferenc Sípos
Cells (2022) Vol. 11, Iss. 15, pp. 2300-2300
Open Access | Times Cited: 105
Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells
Boya Li, Yixiao Xing, Ye-Hua Gan, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 68
Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature
Yusuke Shimizu, Edward Hosea Ntege, Hiroshi Sunami, et al.
Regenerative Therapy (2022) Vol. 21, pp. 527-539
Open Access | Times Cited: 68
New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells
Simin Farokhi, ZahraSadat Razavi, Maryamosadat Mavaei, et al.
Deleted Journal (2024) Vol. 6, Iss. 8
Open Access | Times Cited: 11
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials
Liuting Zeng, Chang Liu, Yang Wu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Human Umbilical Cord Mesenchymal Stem Cells Improve Ovarian Function in Chemotherapy-Induced Premature Ovarian Failure Mice Through Inhibiting Apoptosis and Inflammation via a Paracrine Mechanism
Taoran Deng, Jing He, Q. Y. Yao, et al.
Reproductive Sciences (2021) Vol. 28, Iss. 6, pp. 1718-1732
Closed Access | Times Cited: 50
Characterization of the immunomodulatory properties of alveolar bone-derived mesenchymal stem cells
Cao Chen, Susan A. Tarlé, Darnell Kaigler
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 40
An Update for Mesenchymal Stem Cell Therapy in Lupus Nephritis
Wenchao Li, Weiwei Chen, Lingyun Sun
Kidney Diseases (2021) Vol. 7, Iss. 2, pp. 79-89
Open Access | Times Cited: 38
Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking “Inflammaging” in Patients with Systemic Lupus Erythematosus
Chang‐Youh Tsai, Chieh‐Yu Shen, Hsien‐Tzung Liao, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 16, pp. 3878-3878
Open Access | Times Cited: 39
Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia
Fumihiko Namba
Pediatrics International (2019) Vol. 61, Iss. 10, pp. 945-950
Closed Access | Times Cited: 38
Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren’s syndrome by inducing regulatory T cells
Yanying Liu, Chunlei Li, Shiyao Wang, et al.
Modern Rheumatology (2019) Vol. 31, Iss. 1, pp. 186-196
Closed Access | Times Cited: 37
Exploring the etiopathogenesis of systemic lupus erythematosus: a genetic perspective
Ali Javinani, Amir Ashraf‐Ganjouei, Saeed Aslani, et al.
Immunogenetics (2019) Vol. 71, Iss. 4, pp. 283-297
Closed Access | Times Cited: 33
Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells
Juan Ji, Ting Fu, Chen Dong, et al.
Aging (2019) Vol. 11, Iss. 13, pp. 4338-4353
Open Access | Times Cited: 31
Extracellular vesicles and their cells of origin: Open issues in autoimmune diseases
Azadeh Haghighitalab, Massimo Dominici, Maryam Moghaddam Matin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
The Role of Mesenchymal Stem Cells in Atherosclerosis: Prospects for Therapy via the Modulation of Inflammatory Milieu
Armita Mahdavi Gorabi, Maciej Banach, Željko Reiner, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 9, pp. 1413-1413
Open Access | Times Cited: 28
Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source
Diana M. Carp, Yun Liang
Cells (2022) Vol. 11, Iss. 13, pp. 2077-2077
Open Access | Times Cited: 15
Calcium channels and their role in regenerative medicine
Nassem Ahamad, Brij B. Singh
World Journal of Stem Cells (2021) Vol. 13, Iss. 4, pp. 260-280
Open Access | Times Cited: 20
Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: Results of a phase I clinical trial
Amin Ranjbar, Halimeh Hassanzadeh, Faezeh Jahandoust, et al.
Current Research in Translational Medicine (2021) Vol. 70, Iss. 2, pp. 103324-103324
Closed Access | Times Cited: 18
Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome
Sara Hosseini, Mahmoud Mahmoudi, Zahra Rezaieyazdi, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111306-111306
Closed Access | Times Cited: 7
RETRACTED: Trehalose improves palmitic acid‐induced apoptosis of osteoblasts by regulating SIRT3‐medicated autophagy via the AMPK/mTOR/ULK1 pathway
Lili Cao, Siming Zhou, Xueshan Qiu, et al.
The FASEB Journal (2022) Vol. 36, Iss. 9
Closed Access | Times Cited: 12
The role of mesenchymal stem cell transplantation for ischemic stroke and recent research developments
Lili Zhou, Jiani Wang, Jiagui Huang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 12
The Bone Marrow Microenvironment in Immune-Mediated Inflammatory Diseases: Implications for Mesenchymal Stromal Cell-Based Therapies
Juliana Redondo, Stephen Bailey, Kevin Kemp, et al.
Stem Cells Translational Medicine (2023) Vol. 13, Iss. 3, pp. 219-229
Open Access | Times Cited: 6
Induction Therapy for Lupus Nephritis: the Highlights
Isabelle Ayoub, Jessica Nelson, Brad H. Rovin
Current Rheumatology Reports (2018) Vol. 20, Iss. 10
Closed Access | Times Cited: 16
Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice
Maira Soto, Nicole Delatorre, Chelsie Hurst, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 12
Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes
Jehan J. El‐Jawhari, Payal Ganguly, Elena Jones, et al.
Bioengineering (2021) Vol. 8, Iss. 5, pp. 69-69
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top